| Variables | Neo Multiagent vs Preop XRT | Preop XRT, N = 1,5551 | p-value2 | |
|---|---|---|---|---|
| Overall, N = 7,8521 | Neo Multiagent Chemo, N = 6,2971 | |||
| AGE | 64.00 (57.00, 70.00) | 64.00 (57.00, 70.00) | 65.00 (58.00, 72.00) | <0.001 |
| SEX | 0.71 | |||
| Female | 3,832 (49%) | 3,066 (49%) | 766 (49%) | |
| Male | 4,020 (51%) | 3,231 (51%) | 789 (51%) | |
| RACE.2 | <0.001 | |||
| Black | 687 (8.7%) | 501 (8.0%) | 186 (12%) | |
| Other | 292 (3.7%) | 254 (4.0%) | 38 (2.4%) | |
| White | 6,873 (88%) | 5,542 (88%) | 1,331 (86%) | |
| INSURANCE_STATUS.2 | <0.001 | |||
| Medicaid | 359 (4.6%) | 284 (4.5%) | 75 (4.8%) | |
| Medicare | 3,517 (45%) | 2,786 (44%) | 731 (47%) | |
| Not Insured | 121 (1.5%) | 85 (1.3%) | 36 (2.3%) | |
| Private Insurance/Managed Care/Goverment | 3,746 (48%) | 3,066 (49%) | 680 (44%) | |
| Unknown | 109 (1.4%) | 76 (1.2%) | 33 (2.1%) | |
| MED_INC_QUAR_12 | ||||
| < $38,000 | 1,076 (14%) | 806 (13%) | 270 (17%) | |
| >=$63,000 | 2,736 (35%) | 2,263 (36%) | 473 (30%) | |
| $38,000-$47,999 | 1,799 (23%) | 1,420 (23%) | 379 (24%) | |
| $48,000-$62,999 | 2,217 (28%) | 1,788 (28%) | 429 (28%) | |
| Unknown | 24 (0.3%) | 20 (0.3%) | 4 (0.3%) | |
| NO_HSD_QUAR_12 | ||||
| <7.0% | 2,293 (29%) | 1,898 (30%) | 395 (25%) | |
| >=21.0% | 912 (12%) | 700 (11%) | 212 (14%) | |
| 13.0-20.9% | 1,795 (23%) | 1,402 (22%) | 393 (25%) | |
| 7.0-12.9% | 2,832 (36%) | 2,280 (36%) | 552 (35%) | |
| Unknown | 20 (0.3%) | 17 (0.3%) | 3 (0.2%) | |
| Population.density | 0.17 | |||
| Metro | 6,284 (80%) | 5,054 (80%) | 1,230 (79%) | |
| Rural | 138 (1.8%) | 115 (1.8%) | 23 (1.5%) | |
| Unknown | 204 (2.6%) | 169 (2.7%) | 35 (2.3%) | |
| Urban | 1,226 (16%) | 959 (15%) | 267 (17%) | |
| Charlson.Deyo.Score | <0.001 | |||
| >=3 | 168 (2.1%) | 138 (2.2%) | 30 (1.9%) | |
| 0 | 5,242 (67%) | 4,271 (68%) | 971 (62%) | |
| 1 | 2,019 (26%) | 1,573 (25%) | 446 (29%) | |
| 2 | 423 (5.4%) | 315 (5.0%) | 108 (6.9%) | |
| TNM_CLIN_T | <0.001 | |||
| c1 | 423 (5.4%) | 318 (5.1%) | 105 (6.8%) | |
| c2 | 1,959 (25%) | 1,567 (25%) | 392 (25%) | |
| c3 | 3,786 (48%) | 3,060 (49%) | 726 (47%) | |
| c4 | 1,191 (15%) | 984 (16%) | 207 (13%) | |
| Unknown | 493 (6.3%) | 368 (5.8%) | 125 (8.0%) | |
| TNM_CLIN_N | <0.001 | |||
| c0 | 5,134 (65%) | 4,131 (66%) | 1,003 (65%) | |
| c1 | 2,195 (28%) | 1,779 (28%) | 416 (27%) | |
| Unknown | 523 (6.7%) | 387 (6.1%) | 136 (8.7%) | |
| TNM_PATH_T | <0.001 | |||
| p0 | 234 (3.0%) | 197 (3.1%) | 37 (2.4%) | |
| p1 | 879 (11%) | 707 (11%) | 172 (11%) | |
| p2 | 811 (10%) | 599 (9.5%) | 212 (14%) | |
| p3 | 4,720 (60%) | 3,943 (63%) | 777 (50%) | |
| p4 | 216 (2.8%) | 175 (2.8%) | 41 (2.6%) | |
| Unknown | 992 (13%) | 676 (11%) | 316 (20%) | |
| TNM_PATH_N | <0.001 | |||
| p0 | 3,639 (46%) | 2,847 (45%) | 792 (51%) | |
| p1 | 3,282 (42%) | 2,824 (45%) | 458 (29%) | |
| Unknown | 931 (12%) | 626 (9.9%) | 305 (20%) | |
| ANALYTIC_STAGE_GROUP | <0.001 | |||
| Stage 0 | 74 (0.9%) | 54 (0.9%) | 20 (1.3%) | |
| Stage I | 1,470 (19%) | 1,100 (17%) | 370 (24%) | |
| Stage II | 5,747 (73%) | 4,702 (75%) | 1,045 (67%) | |
| Stage III | 467 (5.9%) | 374 (5.9%) | 93 (6.0%) | |
| Unknown | 94 (1.2%) | 67 (1.1%) | 27 (1.7%) | |
| GRADE.2 | <0.001 | |||
| Moderately differentiated | 2,570 (33%) | 1,999 (32%) | 571 (37%) | |
| Poorly differentiated | 1,537 (20%) | 1,189 (19%) | 348 (22%) | |
| Unknown | 3,187 (41%) | 2,687 (43%) | 500 (32%) | |
| Well differentiated, differentiated | 558 (7.1%) | 422 (6.7%) | 136 (8.7%) | |
| RX_SUMM_SURG_PRIM_SITE.2.2 | 0.016 | |||
| Pancreatectomy, NOS | 79 (1.0%) | 62 (1.0%) | 17 (1.1%) | |
| Partial pancreatectomy, distal | 894 (11%) | 748 (12%) | 146 (9.4%) | |
| Total | 1,061 (14%) | 827 (13%) | 234 (15%) | |
| Whipple | 5,818 (74%) | 4,660 (74%) | 1,158 (74%) | |
| Margins | 0.11 | |||
| R1 | 780 (9.9%) | 640 (10%) | 140 (9.0%) | |
| R2 | 32 (0.4%) | 22 (0.3%) | 10 (0.6%) | |
| Ro | 6,323 (81%) | 5,048 (80%) | 1,275 (82%) | |
| Unknown | 717 (9.1%) | 587 (9.3%) | 130 (8.4%) | |
| Downstaging | <0.001 | |||
| No | 928 (12%) | 801 (13%) | 127 (8.2%) | |
| Unknown | 2,683 (34%) | 2,134 (34%) | 549 (35%) | |
| Yes | 4,241 (54%) | 3,362 (53%) | 879 (57%) | |
| DX_LASTCONTACT_DEATH_MONTHS | 23.00 (14.50, 36.07) | 23.20 (15.11, 35.75) | 21.88 (12.65, 38.38) | 0.012 |
| Unknown | 1,566 | 1,486 | 80 | |
| PUF_VITAL_STATUS.2 | 2,201 (35%) | 1,881 (39%) | 320 (22%) | <0.001 |
| Unknown | 1,565 | 1,485 | 80 | |
|
1
Statistics presented: Median (IQR); n (%)
2
Statistical tests performed: Wilcoxon rank-sum test; chi-square test of independence
|
||||